Literature DB >> 21134617

Botulinum toxin type A in the treatment of Raynaud's phenomenon.

Michael W Neumeister1.   

Abstract

PURPOSE: Raynaud's phenomenon is a vasospastic disorder of the palmar and digital vessels of the hand and feet that can lead to ischemic ulcers, pain, and loss of function. This study is a review of patients I have injected with botulinum toxin type A for patients with Raynaud's phenomenon.
METHODS: Raynaud's patients were injected with 50 to 100 units of onabotulinumtoxinA to improve perfusion of the digits. An institutional review board-approved retrospective review was undertaken to analyze outcomes. Laser Doppler scans were performed before and after injection to quantitatively measure perfusion.
RESULTS: A total of 14 men and 19 women with Raynaud's phenomenon were injected with onabotulinumtoxinA. All but 5 patients experienced improved vascularity and relief of pain. Laser Doppler scans illustrated notable improvement in perfusion. Five patients had repeat injections for recurrent pain.
CONCLUSIONS: Botulinum toxin appears to improve perfusion of the hand after direct injection around the neurovascular bundles. Further investigations are warranted to identify the exact mode of action in relieving vasospasm and alleviating pain.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134617     DOI: 10.1016/j.jhsa.2010.09.019

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  20 in total

Review 1.  Raynaud's phenomenon (secondary).

Authors:  Ariane Herrick; Lindsay Muir
Journal:  BMJ Clin Evid       Date:  2014-10-14

Review 2.  Botulinum Toxin Off-Label Use in Dermatology: A Review.

Authors:  Anna Campanati; Emanuela Martina; Katia Giuliodori; Veronica Consales; Ivan Bobyr; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2017-02-01

3.  The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Ricardo J Bello; Carisa M Cooney; Eitan Melamed; Keith Follmar; Gayane Yenokyan; Gwendolyn Leatherman; Ami A Shah; Fredrick M Wigley; Laura K Hummers; Scott D Lifchez
Journal:  Arthritis Rheumatol       Date:  2017-06-26       Impact factor: 10.995

4.  A Prospective Pilot Study of Vascular Assessment of the Upper Extremity With Laser Angiography.

Authors:  Helen G Hui-Chou; Madhuli Y Thakkar; Kenneth R Means; James P Higgins
Journal:  Hand (N Y)       Date:  2019-03-21

5.  Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience.

Authors:  Mahalakshmi Nagarajan; Paul McArthur
Journal:  Rheumatol Int       Date:  2020-05-23       Impact factor: 2.631

6.  The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toes.

Authors:  Kiran Dhaliwal; Michelle Griffin; Christopher P Denton; Peter E M Butler
Journal:  BMJ Case Rep       Date:  2018-03-09

7.  Botulinum toxin type A suppresses arterial vasoconstriction by regulating calcium sensitization and the endothelium-dependent endothelial nitric oxide synthase/soluble guanylyl cyclase/cyclic guanosine monophosphate pathway: An in vitro study.

Authors:  Liang Hu; Ya Feng; Wuchao Liu; Lingjing Jin; Zhiyu Nie
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-23

8.  Treatment of Raynaud's phenomenon with botulinum toxin type A.

Authors:  Xiaolong Zhang; Yong Hu; Zhiyu Nie; Ye Song; Yougui Pan; Ying Liu; Lingjing Jin
Journal:  Neurol Sci       Date:  2015-01-24       Impact factor: 3.307

9.  Is axillary botulinum toxin efficient in controlling secondary Raynaud's phenomenon? A case report.

Authors:  David DeMasters; Emily Sturgill; Alan Bartholomew
Journal:  J Scleroderma Relat Disord       Date:  2021-07-29

10.  Botulinum Toxin in the Treatment of Vasopressor-associated Symmetric Peripheral Gangrene.

Authors:  Jenna R Stoehr; Aaron M Kearney; Jonathan P Massie; Jason H Ko; Gregory A Dumanian
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.